The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth
Abstract
BACKGROUND: Despite the widespread use of antenatal corticosteroids to prevent respiratory distress syndrome in preterm infants, there is currently no consensus as to the type of corticosteroid to use; nor the dose, frequency, timing of use or the route of administration. OBJECTIVES: To assess the effects of different corticosteroid regimens for women at risk of preterm birth. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (13 February 2013). SELECTION CRITERIA: All identified published and unpublished randomised controlled trials or quasi-randomised control trials comparing any two corticosteroids (dexamethasone or betamethasone or any other corticosteroid that can cross the placenta), comparing different dose regimens (including frequency and timing of administration) in women at risk of preterm birth were included. We planned to exclude cross-over trials and cluster-randomised trials. We included studies published as abstracts only along with studies published as full-text manuscripts DATA COLLECTION AND ANALYSIS: Two review authors independently assessed study eligibility, extracted data and assessed the risk of bias of included studies. Data were checked for accuracy. MAIN RESULTS: For this update, 12 trials (1557 women and 1661 infants) were included. Dexamethasone was associated with a reduced risk of intraventricular haemorrhage (IVH) compared with betamethasone (risk ratio (RR) 0.44, 95% confidence interval (CI) 0.21 to 0.92; four trials, 549 infants). No statistically significant differences were seen for other primary outcomes: respiratory distress syndrome (RDS) (RR 1.06, 95% CI 0.88 to 1.27; five trials, 753 infants) and perinatal death (neonatal death RR 1.41, 95% CI 0.54 to 3.67; four trials, 596 infants). Similarly, very few differences were seen for secondary outcomes such as rate of admission to the neonatal intensive care unit (NICU) although in one trial, those infants exposed to dexamethasone, compared with betamethasone, had a significantly shorter length of NICU admission (mean difference (MD) -0.91 days, 95% CI -1.77 to -0.05; 70 infants). Results for biophysical parameters were inconsistent, but mostly no clinically important differences were seen.Compared with intramuscular dexamethasone, oral dexamethasone significantly increased the incidence of neonatal sepsis (RR 8.48, 95% CI 1.11 to 64.93) in one trial of 183 infants. No statistically significant differences were seen for other outcomes reported.Apart from a reduced maternal postpartum length of stay for women who received betamethasone at 12-hourly intervals compared to 24-hourly intervals in one trial (MD -0.73 days, 95% CI -1.28 to -0.18; 215 women), no differences in maternal or neonatal outcomes were seen between the different betamethasone dosing intervals assessed. Similarly, no significant differences in outcomes were seen when betamethasone acetate and phosphate was compared with betamethasone phosphate in one trial. AUTHORS' CONCLUSIONS: It remains unclear whether one corticosteroid (or one particular regimen) has advantages over another.Dexamethasone may have some benefits compared with betamethasone such as less IVH, and a shorter length of stay in the NICU. The intramuscular route may have advantages over the oral route for dexamethasone, as identified in one small trial. Apart from the suggestion that 12-hour dosing may be as effective as 24-hour dosing of betamethasone based on one small trial, few other conclusions about optimal antenatal corticosteroid regimens were able to be made. No long-term results were available except for a small subgroup of 18 month old children in one trial. Trials comparing the commonly used corticosteroids are most urgently needed, as are trials of dosages and other variations in treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801
An overview of mortality and sequelae of preterm birth from infancy to adulthood
Saigal, S., & Doyle, L. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60136-1 · Cited by 2,818
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub3 · Cited by 2,806
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Born too soon : the Global action report on preterm birth
Howson, C. P., Kinney, M., & Lawn, J. E. (2012) · Cited by 1,928
Basic and Clinical Pharmacology
Katzung, B. G. (1982) · Andalas University Repository (Andalas University) · Cited by 1,914
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., & Dalziel, S. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub2 · Cited by 1,578
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
PREMATURE DELIVERY OF FOETAL LAMBS INFUSED WITH GLUCOCORTICOIDS
LIGGINS, G. C. (1969) · Journal of Endocrinology · doi:10.1677/joe.0.0450515 · Cited by 817
Cited by
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub3 · Cited by 2,806
Mol, B. W. J., Roberts, C. T., Thangaratinam, S., Magee, L. A., de Groot, C. J. M., & Hofmeyr, G. J. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00070-7 · Cited by 1,597
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
McGoldrick, E., Stewart, F., Parker, R., & Dalziel, S. R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub4 · Cited by 614
Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002237 · Cited by 561
Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring
Fox, R., Kitt, J., Leeson, P., Aye, C. Y. L., & Lewandowski, A. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101625 · Cited by 440
Crowther, C. A., McKinlay, C. J., Middleton, P., & Harding, J. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003935.pub3 · Cited by 339
Self-citationPathogenesis and Prevention of Intraventricular Hemorrhage
Ballabh, P. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2013.09.007 · Cited by 319
SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014
Lowe, S. A., Bowyer, L., Lust, K., McMahon, L. P., Morton, M., North, R. A., Paech, M., & Said, J. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12399 · Cited by 299
Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions
the GAPPS Review Group, Barros, F. C., Bhutta, Z. A., Batra, M., Hansen, T. N., Victora, C. G., & Rubens, C. E. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-s1-s3 · Cited by 300
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Plavka, R., Saugstad, O. D., Simeoni, U., Speer, C. P., & Halliday, H. L. (2010) · Neonatology · doi:10.1159/000297773 · Cited by 287
Are animal models relevant to key aspects of human parturition?
Mitchell, B. F., & Taggart, M. J. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2009 · Cited by 265
Westbrook, R. H., Dusheiko, G., & Williamson, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.030 · Cited by 264
Crowther, C. A., McKinlay, C. J., Middleton, P., & Harding, J. E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003935.pub4 · Cited by 255
Self-citationBraun, T., Challis, J. R., Newnham, J. P., & Sloboda, D. M. (2013) · Endocrine Reviews · doi:10.1210/er.2013-1012 · Cited by 196
Interventions to improve neonatal health and later survival: an overview of systematic reviews
Lassi, Z. S., Middleton, P. F., Crowther, C., & Bhutta, Z. A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.023 · Cited by 130
Self-citationAntenatal corticosteroids: a reappraisal of the drug formulation and dose
Jobe, A. H., Kemp, M., Schmidt, A., Takahashi, T., Newnham, J., & Milad, M. (2021) · Pediatric Research · doi:10.1038/s41390-020-01249-w · Cited by 67
Della Torre, M., Hibbard, J. U., Jeong, H., & Fischer, J. H. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.06.029 · Cited by 45
Tuohy, J. F., Bloomfield, F. H., Crowther, C. A., & Harding, J. E. (2021) · PLOS ONE · doi:10.1371/journal.pone.0246175 · Cited by 36
Self-citationPeffer, M. E., Zhang, J. Y., Umfrey, L., Rudine, A. C., Monaghan, A. P., & DeFranco, D. B. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1042 · Cited by 30
Age-dependent effects of prenatal dexamethasone exposure on immune responses in male rats
Chou, M.-Y., Huang, L.-T., Tain, Y.-L., Kuo, H.-C., Tiao, M.-M., Sheen, J.-M., Chen, C.-C., Hung, P.-L., Hsieh, K.-S., & Yu, H.-R. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.241.225 · Cited by 5
Metadata
- Authors
- Brownfoot, F. C., Gagliardi, D. I., Bain, E., Middleton, P., & Crowther, C. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-08-29
- Issue
- 8
- Pages
- CD006764-CD006764
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2105621974
- Cited by
- 343
- References
- 57
- FWCI
- 26.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.